<p>/PRNewswire/ -- Sensura 是一家总部位于新加坡的深科技公司，专注于下一代健康和健康监测，今天宣布将在 <strong>2026 年国际消费电子展（CES 2026）</strong> 上展示其非侵入式健康监测平台，首个监测项目为血糖，展会将于 <strong>2026 年 1 月 6 日至 9 日</strong> 在拉斯维加斯举行。<strong>Sensura 将在 2 号展厅的 35301 号展位展出。</strong></p>
<p>继续阅读</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>Sensura 在拉斯维加斯的 CES 2026 上展示其基于非侵入式高光谱传感的健康监测平台。</p>
<p>在 CES 2026 上，Sensura 将展示一款原型非侵入式血糖监测平台，具有两种互补的设备形态：一种手持设备，旨在快速进行非侵入式的现场检测；另一种可穿戴设备，旨在全天候持续监测血糖趋势。这两款原型设备旨在提供无需刺指或侵入式传感器的血糖洞察，解决传统血糖监测长期存在的挑战。</p>
<p>手持原型设备设计用于临床和家庭环境，能够通过直观操作快速进行非侵入式的现场测量。可穿戴原型设备旨在提供持续的实时血糖趋势洞察，帮助用户更好地理解饮食、活动和生活方式因素如何影响代谢健康。</p>
<p>“长期坚持使用仍然是血糖监测中最重要的挑战之一，” Sensura 的创始人兼首席执行官郑洪志表示。</p>
<p>“当监测过程痛苦或不便时，人们就不太可能持续使用。我们的目标是消除这些障碍，使持续的健康监测在日常生活中更容易维持。”</p>
<p>与大多数现有的血糖监测解决方案依赖于侵入式传感器、频繁更换和重复消耗品不同，Sensura 的非侵入式方法旨在减少长期用户负担，同时支持持续参与。该原型平台结合了专有的光学传感技术、自定义芯片架构和基于 AI 的分析，能够通过舒适的可穿戴形态实现持续的数据捕获。</p>
<p>** 除了在 CES 2026 的 35301 号展位进行现场演示外，**Sensura 还将分享其基础技术架构和产品路线图，概述该平台如何随着时间的推移扩展到更广泛的健康和健康应用。</p>
<p>“CES 是我们从原型开发过渡到验证和战略合作伙伴关系的重要里程碑，” 郑洪志说。</p>
<p>“它使我们能够在我们旅程的关键阶段与全球医疗保健领袖、技术合作伙伴和更广泛的创新生态系统进行互动。”</p>
<p>在 CES 之后，Sensura 的领导团队将在 <strong>摩根大通医疗会议</strong> 期间继续与行业合作伙伴和利益相关者进行讨论，会议将在旧金山举行。</p>
<p><strong>关于 Sensura</strong></p>
<p>Sensura 是一家总部位于新加坡的深科技公司，开发下一代健康和健康监测解决方案。公司总部位于新加坡国立大学的淡马锡生命科学实验室，Sensura 结合了专有的光学传感技术、自定义芯片架构和基于 AI 的分析，能够实现非侵入式、持续和可获取的健康监测。该公司的平台从血糖监测开始，旨在通过可穿戴技术支持早期检测、预防护理和改善长期健康结果，适用于日常使用。</p>
<p>来源：Sensura Pte Ltd</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTA2Jk5ld3NJdGVtSWQ9Q041ODA1NyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMDYyMjE4UFJfTkVXU19VU1BSX19fX19DTjU4MDU3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTA2Jk5ld3NJdGVtSWQ9Q041ODA1NyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMDYyMjE4UFJfTkVXU19VU1BSX19fX19DTjU4MDU3"/></p>

<p>新加坡深科技公司 Sensura 将在 2026 年国际消费电子展（CES）上展示其非侵入式健康监测平台，重点关注血糖监测。该平台包括一个用于快速现场检测的手持设备和一个用于持续监测的可穿戴设备，旨在消除对侵入式传感器的需求。Sensura 的目标是通过提高便利性来改善用户对血糖监测的依从性。该公司还将在 CES 和摩根大通医疗会议上讨论其技术及未来应用</p>

<p>, /PRNewswire/ -- Sensura, a Singapore-based deep-tech company focused on next-generation health and wellness monitoring, today announced that it will showcase its non-invasive health monitoring platform, starting with glucose, at <strong>CES 2026</strong>, taking place from <strong>January 6–9, 2026</strong>, in Las Vegas. <strong>Sensura will be exhibiting at Booth 35301, Hall 2.</strong></p>
<div class="lb-trans"><p>/PRNewswire/ -- Sensura 是一家总部位于新加坡的深科技公司，专注于下一代健康和健康监测，今天宣布将在 <strong>2026 年国际消费电子展（CES 2026）</strong> 上展示其非侵入式健康监测平台，首个监测项目为血糖，展会将于 <strong>2026 年 1 月 6 日至 9 日</strong> 在拉斯维加斯举行。<strong>Sensura 将在 2 号展厅的 35301 号展位展出。</strong></p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>继续阅读</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Sensura presents its non-invasive, hyperspectral sensing–based health monitoring platform at CES 2026 in Las Vegas.</p>
<div class="lb-trans"><p>Sensura 在拉斯维加斯的 CES 2026 上展示其基于非侵入式高光谱传感的健康监测平台。</p>
</div><p>At CES 2026, Sensura will present a prototype non-invasive glucose monitoring platform featuring two complementary device form factors: a handheld device designed for fast, non-invasive spot checks, and a wearable device designed for continuous glucose trend monitoring throughout the day. Both prototypes are designed to deliver glucose insights without finger pricks or invasive sensors, addressing long-standing challenges associated with traditional glucose monitoring.</p>
<div class="lb-trans"><p>在 CES 2026 上，Sensura 将展示一款原型非侵入式血糖监测平台，具有两种互补的设备形态：一种手持设备，旨在快速进行非侵入式的现场检测；另一种可穿戴设备，旨在全天候持续监测血糖趋势。这两款原型设备旨在提供无需刺指或侵入式传感器的血糖洞察，解决传统血糖监测长期存在的挑战。</p>
</div><p>The handheld prototype is designed for both clinical and home settings, enabling rapid, non-invasive spot measurements through intuitive operation. The wearable prototype is designed to provide continuous, real-time glucose trend insights, helping users better understand how diet, activity, and lifestyle factors influence metabolic health over time.</p>
<div class="lb-trans"><p>手持原型设备设计用于临床和家庭环境，能够通过直观操作快速进行非侵入式的现场测量。可穿戴原型设备旨在提供持续的实时血糖趋势洞察，帮助用户更好地理解饮食、活动和生活方式因素如何影响代谢健康。</p>
</div><p>&#34;Long-term adherence remains one of the most significant challenges in glucose monitoring,&#34; said Hongzhi Zheng, Founder and Chief Executive Officer of Sensura.</p>
<div class="lb-trans"><p>“长期坚持使用仍然是血糖监测中最重要的挑战之一，” Sensura 的创始人兼首席执行官郑洪志表示。</p>
</div><p>&#34;When monitoring is painful or inconvenient, people are far less likely to use it consistently. Our goal is to remove those barriers and make continuous health monitoring easier to sustain in everyday life.&#34;</p>
<div class="lb-trans"><p>“当监测过程痛苦或不便时，人们就不太可能持续使用。我们的目标是消除这些障碍，使持续的健康监测在日常生活中更容易维持。”</p>
</div><p>Unlike most existing glucose monitoring solutions that rely on invasive sensors, frequent replacements, and recurring consumables, Sensura's non-invasive approach is designed to reduce long-term user burden while supporting sustained engagement. The prototype platform combines proprietary optical sensing technology, custom chip architecture, and AI-driven analytics to enable continuous data capture through comfortable, wearable form factors.</p>
<div class="lb-trans"><p>与大多数现有的血糖监测解决方案依赖于侵入式传感器、频繁更换和重复消耗品不同，Sensura 的非侵入式方法旨在减少长期用户负担，同时支持持续参与。该原型平台结合了专有的光学传感技术、自定义芯片架构和基于 AI 的分析，能够通过舒适的可穿戴形态实现持续的数据捕获。</p>
</div><p><strong>In addition to live demonstrations at CES 2026 at Booth 35301, Hall 2</strong>, Sensura will share its underlying technology architecture and product roadmap, outlining how the platform may expand beyond glucose monitoring into broader health and wellness applications over time.</p>
<div class="lb-trans"><p>** 除了在 CES 2026 的 35301 号展位进行现场演示外，**Sensura 还将分享其基础技术架构和产品路线图，概述该平台如何随着时间的推移扩展到更广泛的健康和健康应用。</p>
</div><p>&#34;CES represents an important milestone as we transition from prototype development toward validation and strategic partnerships,&#34; Hongzhi Zheng.</p>
<div class="lb-trans"><p>“CES 是我们从原型开发过渡到验证和战略合作伙伴关系的重要里程碑，” 郑洪志说。</p>
</div><p>&#34;It allows us to engage with global healthcare leaders, technology partners, and the broader innovation ecosystem at a pivotal stage of our journey.&#34;</p>
<div class="lb-trans"><p>“它使我们能够在我们旅程的关键阶段与全球医疗保健领袖、技术合作伙伴和更广泛的创新生态系统进行互动。”</p>
</div><p>Following CES, Sensura's leadership team will continue discussions with industry partners and stakeholders during the <strong>J.P. Morgan Healthcare Conference</strong> in San Francisco.</p>
<div class="lb-trans"><p>在 CES 之后，Sensura 的领导团队将在 <strong>摩根大通医疗会议</strong> 期间继续与行业合作伙伴和利益相关者进行讨论，会议将在旧金山举行。</p>
</div><p><strong>About Sensura</strong></p>
<div class="lb-trans"><p><strong>关于 Sensura</strong></p>
</div><p>Sensura is a Singapore-based deep-tech company developing next-generation health and wellness monitoring solutions. Headquartered at the Temasek Life Sciences Laboratory at the National University of Singapore, Sensura combines proprietary optical sensing technology, custom chip architecture, and AI-driven analytics to enable non-invasive, continuous, and accessible health monitoring. Beginning with glucose, the company's platform is designed to support earlier detection, preventive care, and improved long-term health outcomes through wearable technologies intended for everyday use.</p>
<div class="lb-trans"><p>Sensura 是一家总部位于新加坡的深科技公司，开发下一代健康和健康监测解决方案。公司总部位于新加坡国立大学的淡马锡生命科学实验室，Sensura 结合了专有的光学传感技术、自定义芯片架构和基于 AI 的分析，能够实现非侵入式、持续和可获取的健康监测。该公司的平台从血糖监测开始，旨在通过可穿戴技术支持早期检测、预防护理和改善长期健康结果，适用于日常使用。</p>
</div><p>SOURCE Sensura Pte Ltd</p>
<div class="lb-trans"><p>来源：Sensura Pte Ltd</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTA2Jk5ld3NJdGVtSWQ9Q041ODA1NyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMDYyMjE4UFJfTkVXU19VU1BSX19fX19DTjU4MDU3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=CN58057&amp;Transmission_Id=202601062218PR_NEWS_USPR_____CN58057&amp;DateId=20260106"/></p>

Sensura 将在 2026 年 CES 上展示其非侵入式健康监测平台，首先推出葡萄糖监测功能